It’s been a rough ride for Bombardier’s management, workforce, and stock prices; but VP Investor relations Patrick Ghoche says that the company has navigated through the worst of it and is now...
Desautels alumnus John Snisarenko (BSc’86 and MBA’91) has been appointed Group VP of the Ophthalmology Business Unit for Shire US. He comes to Shire from Genentech, where he was VP Sales and...
According to Stockwatch.com, Quantum International Income Corp. has announced that Red Cloud Klondike Strike CEO and Desautels alumnus Chad Williams (BEngr’ 89, MBA’93) has been appointed to its...
Chief Investment Officer’s Class of 2017 Forty Under Forty list is out. It’s a roundup and Q&A with forty up-and-coming investment leaders from across the globe, selected by anonymous nomination.
Wireless broadband solutions specialist Cambium Networks has named Munich-based Tabatha von Kölichen (MBA’91) as the new Regional Sales Director for Germany, Austria and Switzerland, known...
Week seven of the McGill X-1 Accelerator was all about two things: Announcing a transformative $2 million gift from the John Dobson Foundation, and setting up for the upcoming Demo Days.
A recent piece in Poets & Quants for Execs looks at how EMBAs are at a crossroads: As companies are less willing to invest in an EMBA for an employee’s advancement, those execs are looking more...
The Remarketing Under Forty list in Auto Remarketing Canada’s Special Conference Issue is a roundup of the industry’s brightest young minds. Desautels grad Stephanie Turner (MBA'15) is the Senior...
Jonathan Ross Goodman (BA’89, MBA/LLB’93) is the CEO of Montreal-based pharmaceutical company Knight Therapeutics and a Desautels Global Expert. He is also a textbook case of how to overcome...
RSS